Clinical trial
Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung…
NCT00003011 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00003011 |
|---|---|
| Title | Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung Cancer |
| Official title | A Phase III Study of Marimastat in Patients With Small Cell Lung Cancer Following a Response to First Line Chemotherapy |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | marimastat, Placebo |
| Enrollment | 555 |
| Start date | Jan 31, 1997 |
| Primary completion | Feb 13, 2001 |
| Completion | Dec 15, 2008 |
| First posted | Feb 16, 2004 |
| Last update posted | Apr 3, 2020 |
| Countries | Canada |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: